Sentences with phrase «pharmacogenomics working»

There were also lectures about evidence - based dosing based on genotype, by the KNMP Pharmacogenomics Working Group (Dr. Vera Deneer, den Haag, the Netherlands) and the European Medicine Agency Pharmacogenomics Working Party (Dr. Norma Anwar, London, UK).

Professor Markus Paulmichl, director of the Institute of Pharmacology & Toxicology, Paracelsus Medical University and member of the CHMP Pharmacogenomics Working Party, European Medicines Agency, London UK, has agreed to join the PGENI project on behalf of Austria.

This Database was developed jointly with the Global Genomic Medicine Collaborative Pharmacogenomics Working Group and it has been named DruGeVar.

George P. Patrinos currently serves as Associate Professor of Pharmacogenomics at the University of Patras (Greece), and since 2010, as expert and Greece's National representative at the CHMP Pharmacogenomics Working Party of the European Medicines Agency (London, UK).

The Genomics and Pharmacogenomics Working Group aims to undertake and coordinate research projects that will facilitate the integration of genomics applications and pharmacogenomics into healthcare.

deCODE plans to use its pharmacogenomic work to develop and market a test that can be used to target the prescription of glucocorticoids to those patients for whom these compounds provide the most effective relief with the least possible side - effects.

Not exact matches

I continued working at the interface of science and epidemiology, first with Genaissance Pharmaceuticals, a New Haven - based pharmacogenomics company, where I was involved in the fascinating study of human genetic variation and population genetics.

Such collaboration makes sense to Michael Phillips, scientific director of Genome Quebec Pharmacogenomics Centre and the Montreal Heart Institute, who has worked for both industry giants and universities.

Some of her work involves pharmacogenomics, but not all.

Members of the Genome Informatics Working Group have recognized the need to provide a comprehensive resource for pharmacogenomic biomarkers information for those drugs that are approved by regulatory authorities.

The Genomic Medicine Alliance activities are divided into 8 Working Groups, namely Genome Informatics, Pharmacogenomics, Cancer Genomics, Rare Diseases, Public Health Genomics, Economic evaluation in Genomic Medicine, Genethics, and Quality Assurance.

To accomplish these goals, seven working groups were created, including communications, education, evidence, IT / bioinformatics, pharmacogenomics, policy, and a steering group to guide and support efforts among working groups.

Work under the collaboration will be carried out by Encode, deCODE's wholly - owned pharmacogenomics and clinical trials subsidiary.

In the meantime, we are working to develop pharmacogenomic tests that can help to optimize the benefit to patients of currently available treatments.»

In furtherance of their mutual interest in improving fundamental and clinical pharmacogenomics and its translation into clinical practice, the two organizations have agreed: (a) cooperate and collaborate on programs and activities of mutual interest, (b) work together to provide education symposia / workshops in developing countries and regions, and (c) foster collaborative research to better understand the genetic basis for ethnic diversity in the response to and adverse effects from medicines.

Pharmacogenomics: Pharmacogenomics is the study of how a person's genetic makeup affects how medications and medication doses are likely to work best for a particular person or which individuals are more likely to suffer adverse consequences.

Position: Assistant Professor of Pharmacogenomics and Pharmaceutical Biotechnology Organisation: University of Patras Area of work: Bioinformatics, Impact